seres therapeutics stock price target
Get a real-time Seres Therapeutics Inc. The current price of Seres Therapeutics is the price at.
Seres Therapeutics Up By 390 In A Day This Analyst Sees More Upside In The Cards
MCRB stock quote history news and other vital information to help you with your stock trading and investing.
. Find the latest Seres Therapeutics Inc. That Seres Therapeuticss share price could reach 900 by Sep 7 2023. The company has a current ratio of 235 a quick ratio of 235 and a debt-to.
The average Seres Therapeutics stock price prediction forecasts a potential upside of. Analyst Recommendations on SERES THERAPEUTICS INC. Assess the Seres Therapeutics Inc stock price estimates.
Shares of Seres Therapeutics stock opened at 653 on Friday. Analysts covering Seres Therapeutics currently have a. Last 18 months Recommendations Chart SERES THERAPEUTICS INC.
Stock quote stock chart quotes analysis advice financials and news for share SERES THERAPEUTICS INC. MCRB IEX Real-Time Price USD 700. Their MCRB share price forecasts range from 900 to 2500.
Get a real-time Seres Therapeutics Inc. SERES THERAPEUTICS INC. Evolution of the average Target Price on SERES THERAPEUTICS INC.
View todays MCRB stock price trade commission-free and discuss MCRB stock updates with the investor community. MCRB Stock Price Prediction. MCRB is a leading microbiome therapeutics company developing a novel class of multifunctional bacterial consortia that are designed to.
Seres Therapeutics Inc. The analyst consensus target price for shares in Seres Therapeutics is 1314. According to 14 stock analysts the average 12-month stock price.
Target Price consensus revisions. Shares of MCRB opened at 653 on Friday. Find the latest Seres Therapeutics Inc.
Seres Therapeutics Stock Forecast Invest in MCRB NASDAQMCRB. Seres Therapeutics Price Performance Seres Therapeutics stock opened at 681 on Wednesday. 1S9F stock quote history news and other vital information to help you with your stock trading and investing.
Seres Therapeutics has a 1-year low of 250 and a 1-year high of 1169. The stock has a. The average price target is 1533 with a high.
Seres Therapeutics Target Price Projection Seres Therapeutics current and average target prices are 693 and 2283 respectively. Based on short-term price targets offered by five analysts the average price target for Seres Therapeutics comes to 1420. Seres Therapeutics Price Performance.
Stock quotes are provided by. The forecasts range from a low of 900 to a high of. The latest price target for.
Stock quote stock chart quotes analysis advice financials and news for share SERES THERAPEUTICS INC. That is 10467 above the last closing price of 642. Has a 52-week low of 250 and a 52-week high of.
3 equities research analysts have issued 12-month target prices for Seres Therapeutics stock. Seres Therapeutics Inc. Looking to buy Seres Therapeutics Stock.
MCRB was reported by Piper Sandler on September 7 2022The analyst firm set a price target for 900 expecting MCRB to rise to. MCRB stock price quote with breaking news financials statistics charts and more. Based on 4 Wall Street analysts offering 12 month price targets for Seres Therapeutics in the last 3 months.
View analyst opinion as to whether the stock is a strong buy strong sell or hold based on analyst 12-Month MCRB price targets. Seres Therapeutics Price Performance. Deutsche Boerse AG.
The Seres Therapeutics stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst. The Wall Street analyst predicted.
Is Seres Therapeutics Inc Mcrb Stock At The Top Of The Biotechnology Industry
Seres Therapeutics Ser 109 Has Accelerated Growth Potential Nasdaq Mcrb Seeking Alpha
Seres Therapeutics Rallies 14 As Insider Flagship Pioneering Increases Stake Nasdaq
Seres Therapeutics Extends Losses As Goldman Sachs Downgrades On Trial Setback Seeking Alpha
Seres Therapeutics Nasdaq Mcrb Earnings Preview Seres Therapeutics Benzinga
Why Seres Therapeutics Shares Are Popping Off Today Markets Insider
Seres Therapeutics Mcrb Historical Forecast Data Trefis Trefis
Mcrb Stock Price And Chart Nasdaq Mcrb Tradingview
Oppenheimer Research Analysts Lift Earnings Estimates For Seres Therapeutics Inc Nasdaq Mcrb Defense World
Seres Therapeutics Reports Weak Earnings But Significant Upside Lies Ahead
Seres Therapeutics Publishes Positive Ser 287 Phase 1b Ulcerative Colitis Study Results In Journal Gastroenterology Seres Therapeutics
Seres Therapeutics Mcrb Stock Price News Info The Motley Fool
Mcrb Price Target
Seres Therapeutics Big Swing Is Coming Mcrb Stock Mcrb Stock News Seres Therapeutics Stock Youtube
Seres Therapeutics Reiterating Buy Rating With Price Target Increased To 15 Nasdaq Mcrb Seeking Alpha
Seres Therapeutics Nasdaq Mcrb Cut To Sell At Stocknews Com Marketbeat
Growth Investors Industry Analysts Just Upgraded Their Seres Therapeutics Inc Nasdaq Mcrb Revenue Forecasts By 12
Mcrb Seres Therapeutics Inc Cnnmoney Com
Sec Filing Seres Therapeutics